What dose of griseofulvin (125 mg per 5 mL suspension) should be given to a child weighing 21.32 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Griseofulvin Dosing for 21.32 kg Child

For a child weighing 21.32 kg, administer 8.5 mL of griseofulvin 125 mg/5 mL suspension once daily (approximately 20 mg/kg/day), given with a fatty meal for 6-8 weeks.

Dose Calculation

The British Association of Dermatologists guidelines clearly recommend 15-20 mg/kg/day for children under 50 kg 1. Using the standard 20 mg/kg/day dosing:

  • Target dose: 21.32 kg × 20 mg/kg = 426.4 mg daily
  • Volume needed: 426.4 mg ÷ 25 mg/mL = 17 mL daily

Alternatively, using 15 mg/kg (lower end of range):

  • 21.32 kg × 15 mg/kg = 319.8 mg daily = 12.8 mL daily

Practical dosing: Start with 17 mL daily (or divided into 8.5 mL twice daily) to achieve the recommended 20 mg/kg/day.

Key Administration Points

  • Give with fatty food or milk: This is critical as absorption increases 4-fold when administered with milk in pediatric patients, with area under the curve values 10-fold larger 2. This significantly improves bioavailability and ensures more consistent serum levels.

  • Duration: 6-8 weeks for most cases 1

  • Single or divided dosing: Either once daily or split into two doses is acceptable 1

Important Clinical Considerations

When Higher Doses May Be Needed

The guidelines note that doses up to 25 mg/kg/day may be necessary for resistant cases 1. Recent evidence from refugee populations suggests that some Trichophyton violaceum infections may require ≥30 mg/kg/day for complete response when lower doses fail 3. For this child, that would translate to up to 21 mL daily if standard dosing proves inadequate.

Species-Specific Efficacy

Griseofulvin is most effective against Microsporum species (88.5% response rate) but less effective against Trichophyton species (67.9% response rate) 1. If the causative organism is:

  • Microsporum canis/audouinii: Griseofulvin is the preferred agent
  • Trichophyton species: Consider that treatment may need to be prolonged to 12-18 weeks 1

Common Pitfalls to Avoid

  1. Not giving with fatty food: This is the most common error that leads to treatment failure due to poor absorption 2

  2. Premature discontinuation: The endpoint is mycological cure, not clinical cure. Repeat mycology sampling should be performed until clearance is achieved 1

  3. Assuming treatment failure too early: Before declaring treatment failure, verify:

    • Medication compliance
    • Administration with fatty food
    • Correct organism identification
    • Possibility of reinfection 1

Monitoring and Follow-up

  • Peak serum levels occur at approximately 4 hours post-dose 2
  • The drug is deposited in keratin precursor cells and remains in skin longer than plasma 2
  • Children should be allowed to attend school/nursery while on appropriate therapy 1
  • Screen family members and close contacts if Trichophyton tonsurans is identified 1

Safety Profile

Griseofulvin is well-tolerated in children with minor side effects including headaches, gastrointestinal reactions, and cutaneous eruptions 4. No significant adverse effects were observed even at doses up to 30 mg/kg/day 3.

Contraindications: Lupus erythematosus, porphyria, severe liver disease 1

Drug interactions: Plasma concentration decreased by rifampicin and increased by cimetidine 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.